Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Driven by a cyclical rebound across overweight life sciences tools holdings, while initiating turnaround stakes in Biogen and Humana and exiting 14 positions.
Full Quick Take
Driven by a cyclical rebound across overweight life sciences tools holdings, while initiating turnaround stakes in Biogen and Humana and exiting 14 positions.